StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Bristol-Myers Squibb (BMY) falls 12.2% after announcing acquisition of Celgene (CELG)
January 3, 2019 7:07 AM
Bristol-Myers Squibb (NYSE ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Trader Talk
Next Articles
Leerink Partners Downgrades Celgene (CELG) to Market Perform Following Acquisition
January 3, 2019 11:56 AM
Bristol-Myers Squibb (BMY) Announces $5B Accelerated Share Repurchase Program
January 3, 2019 7:12 AM
